Orion Portfolio Solutions’s Genmab GMAB Stock Holding History

Orion Portfolio Solutions’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$416K	Buy	21,263 +3,887	+22%	+$81.5K	﹤0.01%	1492
2024 Q4	$363K	Sell	17,376 -3,919	-18%	-$86.1K	﹤0.01%	1468
2024 Q3	$519K	Buy	21,295 +112	+0.5%	+$2.99K	0.01%	1324
2024 Q2	$532K	Sell	21,183 -1,251	-6%	-$35.5K	0.01%	1253
2024 Q1	$671K	Buy	22,434 +2,186	+11%	+$64.2K	0.01%	1158
2023 Q4	$664K	Sell	20,248 -5,873	-22%	-$184K	0.01%	1102
2023 Q3	$921K	Buy	26,121 +7,322	+39%	+$279K	0.01%	958
2023 Q2	$715K	Sell	18,799 -1,527	-8%	-$60.9K	0.01%	1081
2023 Q1	$767K	Buy	+20,326	New	+$781K	0.01%	988
2020 Q1	–	Sell	-59	Closed	-$1K	–	2047
2019 Q4	$1K	Buy	+59	New	+$1.29K	﹤0.01%	1659

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Orion Portfolio Solutions's GMAB Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Genmab (GMAB) stake by 22% in Q1 2025, buying an estimated $81.5K and bringing the position to 21,263 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

Orion Portfolio Solutions first reported a position in GMAB in Q4 2019 and has held it in 10 quarters since. The position peaked at $921K in Q3 2023. 220 funds tracked by Wall St. Rank hold GMAB as of Q1 2025.

Orion Portfolio Solutions held 21,263 shares of Genmab worth $416K as of Q1 2025.
Orion Portfolio Solutions bought 3,887 Genmab shares in Q1 2025, an estimated $81.5K.
Genmab made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1492 holding.
Orion Portfolio Solutions first reported a position in Genmab in Q4 2019 and has held it in 10 quarters since.
Orion Portfolio Solutions's Genmab position peaked at $921K in Q3 2023.
220 funds tracked by Wall St. Rank held Genmab as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.